| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |